more_reports

Avadel Pharmaceuticals Plc

AVDL:NASDAQ

Avadel Pharmaceuticals is a branded specialty pharmaceutical company. The company's primary focus is on the development and potential FDA approval for FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. In addition, Avadel develops and markets a portfolio of sterile injectable drugs used in the hospital setting.

streetwise book logo Streetwise Company Fact Sheet

2024/11/4 21:50:45

(AVDL:NASDAQ)